Drugs / Cannabis Sativa
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT04316598 | Mar → Jul 2020 | — | Parc de Salut Mar | Terminated | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03813602 | Aug → Nov 2019 | psychiatric disorder | Centre for Addiction and Mental Health | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cannabis Sativa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04316598 ↗ |
| Route | Inhaled | “THC will be administered in the form of medical cannabis (Bedrocan®) inhaled by intrapulmonary route” NCT04316598 ↗ |